Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antisense therapies in neurological diseases

17 Nov 2021

Abstract excerpt

Advances in targeted regulation of gene expression allowed new therapeutic approaches for monogenic neurological diseases. Molecular diagnosis has paved the way to personalized medicine targeting the pathogenic roots: DNA or its RNA transcript. These antisense therapies rely on modified nucleotides sequences (single-strand DNA or RNA, both belonging to the antisense oligonucleotides family, or double-strand...

Topics

Join the communities discussing this publication.

Neurogenetic and Muscular Disorders Research
RNA regulation and disease
RNA Research and Splicing

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35286370
DOI: 10.1093/brain/awab423

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antisense therapies in neurological diseasesPMID 35286370Read ↗

Antisense Drugs Make Sense for Neurological DiseasesSemantic proximity Read ↗

Antisense therapies for movement disordersSemantic proximity Read ↗

Antisense oligonucleotides and other genetic therapies made simpleSemantic proximity Read ↗

Therapeutic antisense oligonucleotides for movement disordersSemantic proximity Read ↗

Antisense Oligonucleotide Therapy for the Nervous System: From Bench to Bedside with Emphasis on Pediatric NeurologySemantic proximity Read ↗

Antisense oligonucleotides and their applications in rare neurological diseasesSemantic proximity Read ↗

Antisense oligonucleotide therapeutics in neurodegenerative diseases: the case of polyglutamine disordersSemantic proximity Read ↗

The expanding application of antisense oligonucleotides to neurodegenerative diseasesSemantic proximity Read ↗

Antisense Oligonucleotide-Based Therapy for Neuromuscular DiseaseSemantic proximity Read ↗

Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseasesSemantic proximity Read ↗

Antisense oligonucleotides: A promising advancement in neurodegenerative disease treatmentSemantic proximity Read ↗

Antisense oligonucleotide therapeutics for inherited neurodegenerative diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.